Managing conditions in a bioreactor is critical for successful bioprocessing. This is especially so when dealing with fragile cultures such as CHO cells, where pH levels are crucial for encouraging growth and production. Traditional electrochemical probes have been favored for monitoring pH due to
The biopharmaceutical sector is experiencing rapid innovation as therapies like monoclonal antibodies and gene treatments push towards market approval. The cornerstone for ensuring their market readiness is rigorous and extensive testing, which is a significant growth factor for the
Rising Reliance on AI Decision-Making In a turn of events bringing the complexity of artificial intelligence (AI) to the political forefront, the Australian Senate is critically examining the growing utilization of AI in governmental decision-making processes, particularly within the immigration
The Industrial Internet of Things (IIoT) is revolutionizing biomanufacturing, a crucial element of the broader movement toward Industry 4.0. By leveraging the power of interconnected devices and systems, bioprocessing facilities are experiencing a surge in productivity and operational efficiency.
The biopharmaceutical manufacturing landscape is undergoing a significant transformation, with the emergence of continuous bioprocessing as a key innovative approach. This article will explore the various facets of this paradigm shift and its impact on the industry. The Shift from Traditional Batch
Certainly! Here is the content formatted with the appropriate heading designations: The synthetic biology sector is on a trajectory to monumental expansion, expected to reach a valuation of $52.6 billion by 2030. This interdisciplinary field combines biology, engineering, computer science, and
